Download PDF
Semin Neurol 2007; 27(2): 123-132
DOI: 10.1055/s-2007-971173
Copyright © 2007 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Wilson's Disease

Ronald F. Pfeiffer1
  • 1Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee
Further Information

Publication History

Publication Date:
27 March 2007 (online)

   Permissions and Reprints

ABSTRACT

Wilson's disease is an autosomal-recessive disorder caused by mutation in the ATP7B gene, with resultant impairment of biliary excretion of copper. Subsequent copper accumulation, first in the liver but ultimately in the brain and other tissues, produces protean clinical manifestations that may include hepatic, neurological, psychiatric, ophthalmological, and other derangements. Genetic testing is impractical because of the multitude of mutations that have been identified, so accurate diagnosis relies on judicious use of a battery of laboratory and other diagnostic tests. Lifelong palliative treatment with a growing stable of medications, or with liver transplantation if needed, can successfully ameliorate or prevent the progressive deterioration and eventual death that would otherwise inevitably ensue. This article discusses the epidemiology, genetics, pathophysiology, clinical features, diagnostic testing, and treatment of Wilson's disease.

KEYWORDS

Ceruloplasmin - copper - Wilson's disease - penicillamine - zinc

REFERENCES

  • 1 Walshe J M. History of Wilson's disease: 1912 to 2000.  Mov Disord. 2006;  21 142-147
    CrossrefPubMedSearch in Google Scholar
  • 2 Wilson S AK. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver.  Brain. 1912;  34 295-507
    CrossrefPubMedSearch in Google Scholar
  • 3 Kayser B. Uber einen Fall von angeborener grünlicher Verfärbung der Kornea.  Klin Monatsbl Augenheilkd. 1902;  40 22-25
    PubMedSearch in Google Scholar
  • 4 Fleischer B. Zwei weiterer Falle von grünlicher Verfärbung der Kornea.  Klin Monatsbl Augenheilkd. 1903;  41 489-491
    PubMedSearch in Google Scholar
  • 5 Fleischer B. Uber eine der “Pseudosklerose” nahestehende, bisher unbekannte Krankheit (gekennzeichnet durch tremor, psychische storungen, braunliche Pigmentierung bestimmter gewebe, inbesondere auch der Hornhautperipherie, Lebercirrhose).  Dtsch Z Nervenheilkd. 1912;  44 179-201
    CrossrefPubMedSearch in Google Scholar
  • 6 Rumpel A. Über das Wesen und die Bedeutung der Leberveränderungen und der Pigmentierunen bei den damit verbundenen Fällen von Psuedosklerose, zugleich ein Beitrag zur Lehre von der Pseudosklerose (Westphal-Strümpell).  Dtsch Z Nervenheilkd. 1913;  49 54-73
    CrossrefPubMedSearch in Google Scholar
  • 7 Mandelbrote B M, Stanier M W, Thompson R HS, Thurston M N. Studies on copper metabolism in demyelinating diseases of the central nervous system.  Brain. 1948;  71 212-228
    CrossrefPubMedSearch in Google Scholar
  • 8 Cumings J N. The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration.  Brain. 1948;  71 410-415
    PubMedSearch in Google Scholar
  • 9 Scheinberg I H, Gitlin D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease).  Science. 1952;  116 484-485
    CrossrefPubMedSearch in Google Scholar
  • 10 Bearn A G, Kunkel H G. Biochemical abnormalities in Wilson's disease.  J Clin Invest. 1952;  31 616
    PubMedSearch in Google Scholar
  • 11 Frommer D J. Defective biliary excretion of copper in Wilson's disease.  Gut. 1974;  15 125-129
    PubMedSearch in Google Scholar
  • 12 Saito T. An assessment of efficiency in potential screening for Wilson's disease.  J Epidemiol Community Health. 1981;  35 274-280
    PubMedSearch in Google Scholar
  • 13 Scheinberg I H, Sternlieb I. Wilson's Disease. Philadelphia; WB Saunders 1984
    Search in Google Scholar
  • 14 Brewer G J. Wilson's Disease: A Clinician's Guide to Recognition, Diagnosis, and Management. Boston; Kluwer Academic Publishers 2001
    Search in Google Scholar
  • 15 Olivarez L, Caggana M, Pass K A, Ferguson P, Brewer G J. Estimate of the frequency of Wilson's disease in the US Caucasian population: a mutation analysis approach.  Ann Hum Genet. 2001;  65 459-463
    CrossrefPubMedSearch in Google Scholar
  • 16 Bull P C, Thomas G R, Rommens J M, Forbes J R, Cox D W. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene.  Nat Genet. 1993;  5 327-337
    CrossrefPubMedSearch in Google Scholar
  • 17 Petrukhin K, Fischer S G, Piratsu M et al.. Mapping, cloning and genetic characterization of the region containing the Wilson disease gene.  Nat Genet. 1993;  5 338-343
    CrossrefPubMedSearch in Google Scholar
  • 18 Yamaguchi Y, Heiny M E, Gitlin J D. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease.  Biochem Biophys Res Commun. 1993;  197 271-277
    CrossrefPubMedSearch in Google Scholar
  • 19 Petrukhin K, Lutsenko S, Chernov I, Ross B M, Kaplan J H, Gilliam T C. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions.  Hum Mol Genet. 1994;  3 1647-1656
    PubMedSearch in Google Scholar
  • 20 Cox D W, Prat L, Walshe J M, Heathcote J, Gaffney D. Twenty-four novel mutations in Wilson disease patients of predominantly European ancestry.  Hum Mutat. 2005;  26 280-286
    PubMedSearch in Google Scholar
  • 21 Loudianos G, Lovicu M, Dessi V et al.. Abnormal mRNA splicing resulting from consensus sequence splicing mutations of ATP7B.  Hum Mutat. 2002;  20 260-266
    CrossrefPubMedSearch in Google Scholar
  • 22 Gromadzka G, Schmidt H H, Genschel J et al.. p.H1069Q mutation in ATP7B and biochemical parameters of copper metabolism and clinical manifestation of Wilson's disease.  Mov Disord. 2006;  21 245-248
    CrossrefPubMedSearch in Google Scholar
  • 23 Vrabelova S, Letocha O, Borsky M, Kozak L. Mutation analysis of the ATP7B gene and genotype/phenotype correlation in 227 patients with Wilson disease.  Mol Genet Metab. 2005;  86 277-285
    CrossrefPubMedSearch in Google Scholar
  • 24 Gromadzka G, Schmidt H H-J, Genschel J et al.. Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson's disease.  Clin Genet. 2005;  68 524-532
    CrossrefPubMedSearch in Google Scholar
  • 25 Senzolo M, Loreno M, Fagiuoli S et al.. Different neurological outcome of liver transplantation for Wilson's disease in two homozygotic twins.  Clin Neurol Neurosurg. 2007;  109 71-75
    CrossrefPubMedSearch in Google Scholar
  • 26 Grubenbecher S, Stüve O, Hefter H, Korth C. Prion protein gene codon 129 modulates clinical course of neurological Wilson disease.  Neuroreport. 2006;  17 549-552
    CrossrefPubMedSearch in Google Scholar
  • 27 Merle U, Stremmel W, Gessner R. Influence of homozygosity for methionine at codon 129 of the human prion gene on the onset of neurological and hepatic symptoms in Wilson disease.  Arch Neurol. 2006;  63 982-985
    CrossrefPubMedSearch in Google Scholar
  • 28 Sechi G, Antonio Cocco G A, Errigo A et al.. Three sisters with very-late-onset major depression and parkinsonism.  Parkinsonism Relat Disord. 2006; May 29;  , (Epub ahead of print)
    PubMedSearch in Google Scholar
  • 29 Hung I H, Suzuki M, Yamaguchi Y, Yuan D S, Klausner R D, Gitlin J D. Biochemical characterization of the Wilson disease protein and functional expression in the yeast Saccharomyces cerevisiae .  J Biol Chem. 1997;  272 21461-21466
    CrossrefPubMedSearch in Google Scholar
  • 30 La Fontaine S, Theophilos M B, Firth S D, Gould R, Parton R G, Mercer J F. Effect of the toxic milk mutation (tx) on the function and intracellular localization of Wnd, the murine homologue of the Wilson copper ATPase.  Hum Mol Genet. 2001;  10 361-370
    CrossrefPubMedSearch in Google Scholar
  • 31 Forbes J R, Cox D W. Copper-dependent trafficking of Wilson disease mutant ATP7B proteins.  Hum Mol Genet. 2000;  9 1927-1935
    CrossrefPubMedSearch in Google Scholar
  • 32 Mufti A R, Burstein E, Csomos R A et al.. XIAP is a copper binding protein deregulated in Wilson's disease and other copper toxicosis disorders.  Mol Cell. 2006;  21 775-785
    CrossrefPubMedSearch in Google Scholar
  • 33 Gibbs K, Walshe M. A study of the ceruloplasmin concentrations found in 75 patients with Wilson's disease, their kinships and various control groups.  Q J Med. 1979;  48 447-463
    PubMedSearch in Google Scholar
  • 34 Walshe J M. Wilson's disease: the presenting symptoms.  Arch Dis Child. 1962;  37 253-256
    PubMedSearch in Google Scholar
  • 35 Walshe J M. Wilson's disease (HLD). In: Vinken PJ, Bruyn GW Handbook of Clinical Neurology. Vol. 27. Amsterdam; North Holland Publishing Company 1976: 379-414
    Search in Google Scholar
  • 36 Beyersdorff A, Findeisen A. Morbus Wilson: case report of a two-year-old child as first manifestation.  Scand J Gastroenterol. 2006;  41 496-497
    CrossrefPubMedSearch in Google Scholar
  • 37 Gow P J, Smallwood R A, Angus P W, Smith A L, Wall A J, Sewell R B. Diagnosis of Wilson's disease: an experience over three decades.  Gut. 2000;  46 415-419
    CrossrefPubMedSearch in Google Scholar
  • 38 Sternlieb I, Scheinberg I H. Chronic hepatitis as a first manifestation of Wilson's disease.  Ann Intern Med. 1972;  76 59-64
    PubMedSearch in Google Scholar
  • 39 Scott J, Gollan J L, Samourian S, Sherlock S. Wilson's disease presenting as chronic active hepatitis.  Gastroenterology. 1978;  74 645-651
    PubMedSearch in Google Scholar
  • 40 Schilsky M L, Fink S. Inherited metabolic liver disease.  Curr Opin Gastroenterol. 2006;  22 215-222
    PubMedSearch in Google Scholar
  • 41 Schilsky M L, Scheinberg I H, Sternlieb I. Liver transplantation for Wilson's disease: indications and outcome.  Hepatology. 1994;  19 583-587
    PubMedSearch in Google Scholar
  • 42 Roche-Sicot J, Benhamou J P. Acute intravascular hemolysis and acute liver failure associated as a first manifestation of Wilson's disease.  Ann Intern Med. 1977;  86 301-303
    PubMedSearch in Google Scholar
  • 43 Strickland G T, Leu M L. Wilson's disease: clinical and laboratory manifestations in 40 patients.  Medicine. 1975;  54 113-137
    PubMedSearch in Google Scholar
  • 44 Ala A, Borjigin J, Rochwarger A, Schilsky M. Wilson disease in septuagenarian siblings: raising the bar for diagnosis.  Hepatology. 2005;  41 668-670
    CrossrefPubMedSearch in Google Scholar
  • 45 Hellman N E, Gitlin J D. Ceruloplasmin metabolism and function.  Annu Rev Nutr. 2002;  22 439-458
    CrossrefPubMedSearch in Google Scholar
  • 46 Parker N. Hereditary whispering dysphonia.  J Neurol Neurosurg Psychiatry. 1985;  48 218-224
    PubMedSearch in Google Scholar
  • 47 Cartwright G E. Diagnosis of treatable Wilson's disease.  N Engl J Med. 1978;  298 1347-1350
    PubMedSearch in Google Scholar
  • 48 Walshe J M, Yealland M. Wilson's disease: the problem of delayed diagnosis.  J Neurol Neurosurg Psychiatry. 1992;  55 692-696
    PubMedSearch in Google Scholar
  • 49 Svetel M, Kozic D, Stefanova E, Semnic R, Dragasevic N, Kostic V S. Dystonia in Wilson's disease.  Mov Disord. 2001;  16 719-723
    CrossrefPubMedSearch in Google Scholar
  • 50 Barbosa E R, Silveira-Moriyama L, Machado A C, Bacheschi L A, Rosemberg S, Scaff M. Wilson's disease with myoclonus and white matter lesions.  Parkinsonism Relat Disord. 2006; May 30;  (Epub ahead of print) 
    PubMedSearch in Google Scholar
  • 51 Papapetropoulos S, Singer C. Painless legs moving toes in a patient with Wilson's disease.  Mov Disord. 2006;  21 579-580
    CrossrefPubMedSearch in Google Scholar
  • 52 Bhattacharya K, Velickovic M, Schilsky M, Kaufmann H. Autonomic cardiovascular reflexes in Wilson's disease.  Clin Auton Res. 2002;  12 190-192
    CrossrefPubMedSearch in Google Scholar
  • 53 Meenakshi-Sundaram S, Taly A B, Kamath V, Arunodaya G R, Rao S, Swamy H S. Autonomic dysfunction in Wilson's disease: a clinical and electrophysiological study.  Clin Auton Res. 2002;  12 185-189
    CrossrefPubMedSearch in Google Scholar
  • 54 Dening T R, Berrios G E, Walshe J M. Wilson's disease and epilepsy.  Brain. 1988;  111 1139-1155
    CrossrefPubMedSearch in Google Scholar
  • 55 Polychronopoulos P, Argyriou A A, Papapetropoulos S, Gourzis P, Rigas G, Chroni E. Wilson's disease and benign epilepsy of childhood with centrotemporal (rolandic) spikes.  Epilepsy Behav. 2006;  8 438-441
    CrossrefPubMedSearch in Google Scholar
  • 56 Kumar S. Wilson's disease presenting as status epilepticus.  Indian Pediatr. 2005;  42 492-493
    PubMedSearch in Google Scholar
  • 57 Jung K H, Ahn T B, Jeon B S. Wilson disease with an initial manifestation of polyneuropathy.  Arch Neurol. 2005;  62 1628-1631
    CrossrefPubMedSearch in Google Scholar
  • 58 Mueller A, Reuner U, Landis B, Kitzler H, Reichmann H, Hummel T. Extrapyramidal symptoms in Wilson's disease are associated with olfactory dysfunction.  Mov Disord. 2006;  21 1311-1316
    CrossrefPubMedSearch in Google Scholar
  • 59 Akil M, Schwartz J A, Dutchak D, Yuzbasiyan-Gurkan V, Brewer G J. The psychiatric presentations of Wilson's disease.  J Neuropsychiatry Clin Neurosci. 1991;  3 377-382
    PubMedSearch in Google Scholar
  • 60 Brewer G J. Behavioral abnormalities in Wilson's disease.  Adv Neurol. 2005;  96 262-274
    PubMedSearch in Google Scholar
  • 61 Oder W, Grimm G, Kollegger H, Ferenci P, Schneider B, Deecke L. Neurological and neuropsychiatric spectrum of Wilson's disease: a prospective study of 45 cases.  J Neurol. 1991;  238 281-287
    PubMedSearch in Google Scholar
  • 62 Dening T R. Psychiatric aspects of Wilson's disease.  Br J Psychiatry. 1985;  147 677-682
    PubMedSearch in Google Scholar
  • 63 Kaul A, McMahon D. Wilson's disease and offending behavior: a case report.  Med Sci Law. 1993;  33 353-358
    PubMedSearch in Google Scholar
  • 64 Seniow J, Bak T, Gajda J, Poniatowska R, Czlonkowska A. Cognitive functioning in neurologically symptomatic and asymptomatic forms of Wilson's disease.  Mov Disord. 2002;  17 1077-1083
    CrossrefPubMedSearch in Google Scholar
  • 65 Portala K, Levander S, Westermark K, Ekselius L, von Knorring L. Pattern of neuropsychological deficits in patients with treated Wilson's disease.  Eur Arch Psychiatry Clin Neurosci. 2001;  251 262-268
    CrossrefPubMedSearch in Google Scholar
  • 66 Gronlund J, Nanto-Salonen K, Venetoklis J, Holmberg R L, Heinonen A, Stahlberg M R. Poor cognitive development and abdominal pain: Wilson's disease.  Scand J Gastroenterol. 2006;  41 361-364
    CrossrefPubMedSearch in Google Scholar
  • 67 Brewer G J. Recognition, diagnosis, and management of Wilson's disease.  Proc Soc Exp Biol Med. 2000;  223 39-46
    PubMedSearch in Google Scholar
  • 68 Wiebers D O, Hollenhorst R W, Goldstein N P. The ophthalmologic manifestations of Wilson's disease.  Mayo Clin Proc. 1977;  52 409-416
    PubMedSearch in Google Scholar
  • 69 Johnson R E, Campbell R J. Wilson's disease: electron microscopic, x-ray energy spectroscopic, and atomic absorption spectroscopic studies of corneal copper deposition and distribution.  Lab Invest. 1982;  46 564-569
    PubMedSearch in Google Scholar
  • 70 Innes J R, Strachan I M, Triger D R. Unilateral Kayser-Fleischer ring.  Br J Ophthalmol. 1986;  70 469-470
    PubMedSearch in Google Scholar
  • 71 Sussman W, Scheinberg I H. Disappearance of Kayser-Fleischer rings: effects of penicillamine.  Arch Ophthalmol. 1969;  82 738-741
    PubMedSearch in Google Scholar
  • 72 Ross M E, Jacobson I M, Dienstag D L, Martin J B. Late onset Wilson's disease with neurological involvement in the absence of Kayser-Fleischer rings.  Ann Neurol. 1985;  17 411-413
    CrossrefPubMedSearch in Google Scholar
  • 73 Pfeiffer R F. Wilson's disease. In: Watts RL, Koller WC Movement Disorders. Neurologic Principles and Practice. New York; McGraw-Hill Medical Publishers 2004: 779-797
    Search in Google Scholar
  • 74 Siemerling E, Oloff H. Pseudosklerose (Westphal-Strümpell) mit Cornealring (Kayser-Fleischer) und doppelseitiger Scheinkatarakt, die nur bei seitlicher Beleuchtnung sichtbar ist und die der nach Verletzung durch Kupfersplitter entstehenden Katarakt änlich ist.  Klin Wochenschr. 1922;  1 1087-1089
    CrossrefPubMedSearch in Google Scholar
  • 75 Cairns J E, Williams H P, Walshe J M. “Sunflower cataract” in Wilson's disease.  Br Med J. 1969;  3 95-96
    PubMedSearch in Google Scholar
  • 76 Golding D N, Walshe J M. Arthropathy of Wilson's disease: study of clinical and radiological features in 32 patients.  Ann Rheum Dis. 1977;  36 99-111
    PubMedSearch in Google Scholar
  • 77 Canelas H M, Carvalho N, Scaff M, Vitule A, Barbosa E R, Azevedo E M. Osteoarthropathy of hepatolenticular degeneration.  Acta Neurol Scand. 1978;  57 481-487
    PubMedSearch in Google Scholar
  • 78 Mindelzun R, Elkin M, Scheinberg I H, Sternlieb I. Skeletal changes in Wilson's disease: a radiological study.  Radiology. 1970;  94 127-132
    PubMedSearch in Google Scholar
  • 79 Yarze J C, Martin P, Munoz S J, Friedman L S. Wilson's disease: current status.  Am J Med. 1992;  92 643-654
    CrossrefPubMedSearch in Google Scholar
  • 80 McIntyre N, Clink H M, Levi A J, Cumings J N, Sherlock S. Hemolytic anemia in Wilson's disease.  N Engl J Med. 1967;  276 439-444
    PubMedSearch in Google Scholar
  • 81 Sternlieb I. Wilson's disease: indications for liver transplants.  Hepatology. 1984;  4 15S-17S
    PubMedSearch in Google Scholar
  • 82 Donfrid M, Jankovic G, Strahinja R, Colovic R, Begic-Janeva A, Colovic M. Idiopathic thrombocytopenia associated with Wilson's disease.  Hepatogastroenterology. 1998;  45 1774-1776
    PubMedSearch in Google Scholar
  • 83 Atanassova P A, Panchovska M S, Tzvetanov P, Chalakova N T, Masaldzhieva R I, Dimitrov B D. Hepatolenticular degeneration combined with primary antiphospholipid syndrome: a case report.  Eur Neurol. 2006;  55 42-43
    CrossrefPubMedSearch in Google Scholar
  • 84 Wiebers D O, Wilson D M, McLeod R A, Goldstein N P. Renal stones in Wilson's disease.  Am J Med. 1979;  67 249-254
    CrossrefPubMedSearch in Google Scholar
  • 85 Narayanan P, Chetan G, Mahadevan S. Wilson's disease presenting as respiratory failure.  Indian J Pediatr. 2006;  73 99-100
    PubMedSearch in Google Scholar
  • 86 Leu M L, Strickland G T, Wang C C, Chen T S. Skin pigmentation in Wilson's disease.  JAMA. 1970;  211 1542-1543
    CrossrefPubMedSearch in Google Scholar
  • 87 Scheinberg I H, Sternlieb I. Wilson's disease.  Annu Rev Med. 1965;  16 119-134
    CrossrefPubMedSearch in Google Scholar
  • 88 Lau J Y, Lai C L, Wu P C, Pan H Y, Lin H J, Todd D. Wilson's disease: 35 years' experience.  Q J Med. 1990;  75 597-605
    PubMedSearch in Google Scholar
  • 89 Ferenci P, Steindl-Munda P, Vogel W et al.. Diagnostic value of quantitative hepatic copper determination in patients with Wilson's disease.  Clin Gastroenterol Hepatol. 2005;  3 811-818
    CrossrefPubMedSearch in Google Scholar
  • 90 Smallwood R A, Williams H A, Rosenoer V M, Sherlock S. Liver-copper levels in liver disease: studies using neutron activation analysis.  Lancet. 1968;  2 1310-1313
    PubMedSearch in Google Scholar
  • 91 Benson G D. Hepatic copper accumulation in primary biliary cirrhosis.  Yale J Biol Med. 1979;  52 83-88
    PubMedSearch in Google Scholar
  • 92 Willeit J, Kiechl S G. Wilson's disease with neurologic impairment but no Kayser-Fleischer rings.  Lancet. 1991;  337 1426
    PubMedSearch in Google Scholar
  • 93 Oracz G, Klimczak-Slaczka D, Sokolowska-Oracz A et al.. [Prevalence of Kayser-Fleischer ring in patients with Wilson's disease]. [In Polish].  Klin Oczna. 2005;  107 54-56
    PubMedSearch in Google Scholar
  • 94 Das S K, Ray K. Wilson's disease: an update.  Nat Clin Pract Neurol. 2006;  2 482-493
    CrossrefPubMedSearch in Google Scholar
  • 95 Sinha S, Taly A B, Ravishankar S et al.. Wilson's disease: cranial MRI observations and clinical correlation.  Neuroradiology. 2006;  48 613-621
    CrossrefPubMedSearch in Google Scholar
  • 96 Walter U, Krolikowski K, Tarnacka B, Benecke R, Czlonkowska A, Dressler D. Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease.  Neurology. 2005;  64 1726-1732
    CrossrefPubMedSearch in Google Scholar
  • 97 Hartard C, Weisner B, Dieu C, Kunze K. Wilson's disease with cerebral manifestation: monitoring therapy by CSF copper concentration.  J Neurol. 1993;  241 101-107
    PubMedSearch in Google Scholar
  • 98 Hoogenraad T U. Paradigm shift in the treatment of Wilson's disease: zinc therapy now treatment of choice.  Brain Dev. 2006;  28 141-146
    CrossrefPubMedSearch in Google Scholar
  • 99 Walshe J M. Penicillamine, a new oral therapy for Wilson's disease.  Am J Med. 1956;  21 487-495
    CrossrefPubMedSearch in Google Scholar
  • 100 Brewer G J, Askari F, Lorincz M T et al.. Treatment of Wilson disease with ammonium tetrathiomolybdate.  Arch Neurol. 2006;  63 521-527
    CrossrefPubMedSearch in Google Scholar
  • 101 Walshe J M, Yealland M. Chelation treatment of neurological Wilson's disease.  Q J Med. 1993;  86 197-204
    PubMedSearch in Google Scholar
  • 102 Brewer G J, Terry C A, Aisen A M, Hill G M. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy.  Arch Neurol. 1987;  44 490-493
    CrossrefPubMedSearch in Google Scholar
  • 103 Prashanth L K, Taly A B, Sinha S et al.. Prognostic factors in patients presenting with severe neurological forms of Wilson's disease.  QJM. 2005;  98 557-563
    CrossrefPubMedSearch in Google Scholar
  • 104 Sternlieb I, Scheinberg I H. Penicillamine therapy for hepatolenticular degeneration.  JAMA. 1964;  189 748-754
    PubMedSearch in Google Scholar
  • 105 Haggstrom G D, Hirschowitz B I, Flint A. Long-term penicillamine therapy for Wilson's disease.  South Med J. 1980;  73 530-531
    PubMedSearch in Google Scholar
  • 106 Sternlieb I, Fisher M, Scheinberg I H. Penicillamine-induced skin lesions.  J Rheumatol Suppl. 1981;  7 149-154
    PubMedSearch in Google Scholar
  • 107 Walshe J M. Penicillamine: the treatment of first choice for patients with Wilson's disease.  Mov Disord. 1999;  14 545-550
    CrossrefPubMedSearch in Google Scholar
  • 108 Schafer D F, Shaw Jr B W. Fulminant hepatic failure and orthotopic liver transplantation.  Semin Liver Dis. 1989;  9 189-194
    PubMedSearch in Google Scholar
  • 109 Medici V, Mirante V G, Fassati L R et al.. Liver transplantation for Wilson's disease: the burden of neurological and psychiatric disorders.  Liver Transpl. 2005;  11 1056-1063
    CrossrefPubMedSearch in Google Scholar
  • 110 Wang X H, Cheng F, Zhang F et al.. Living-related liver transplantation for Wilson's disease.  Transpl Int. 2005;  18 651-656
    CrossrefPubMedSearch in Google Scholar
  • 111 Tamura S, Sugawara Y, Kishi Y, Akamatsu N, Kaneko J, Makuuchi M. Living-related liver transplantation for Wilson's disease.  Clin Transplant. 2005;  19 483-486
    CrossrefPubMedSearch in Google Scholar

Ronald F PfeifferM.D. 

Professor and Vice Chair, Department of Neurology, University of Tennessee Health Science Center

855 Monroe Avenue, Memphis, TN 38163